Please use this identifier to cite or link to this item:
|Title:||The delayed diagnosis of myeloproliferative neoplasms is common and results in a high incidence of potentially preventable thrombotic complications||Authors:||Forsyth, Cecily J ;Melville, K.;Tiley, Campbell||Affliation:||Central Coast Local Health District
|Issue Date:||Dec-2018||Source:||50(7):775-776||Journal title:||Pathology||Department:||Haematology||Abstract:||This article discusses delayed diagnosis of myeloproliferative neoplasms (MPN). A retrospective chart review was performed to determine the duration of blood count abnormalities prior to diagnosis and the incidence of potentially preventable thrombotic and haemorrhagic complications occurring during this time. A significant delay from the appearance of MPN associated blood count abnormalities until the diagnosis of a MPN was established. During the time from first appearance of a blood count abnormality until diagnosis with a MPN, 25% of patients experience a potentially preventable adverse event. Factors identified in contributing to delays in diagnosis include a lack of familiarity of general practitioners and non haematologist physicians with MPN-associated blood abnormalities, laboratories not adequately emphasising the possibility of a diagnosis of MPN and not making recommendations for confirmation and further testing.||URI:||https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1284||DOI:||10.1016/j.pathol.2018.05.010||Pubmed:||https://www.ncbi.nlm.nih.gov/pubmed/30262184||ISSN:||0031-3025||Publicaton type:||Journal Article||Keywords:||Haematology
|Appears in Collections:||Haematology|
Show full item record
checked on Jun 3, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.